Moderna, Inc. (MRNA)

SEC filing

Moderna, Inc.

MRNA · CIK 1682852

4 · Sep 14, 2026 · Chief Financial Officer Mock James M sold 34.84K shares at $134.49/share ($4.7M); exercised options for 39.67K shares

Chief Financial Officer Mock James M sold 34.84K shares at $134.49/share ($4.7M); exercised options for 39.67K shares

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).